RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Benitec Biopharma Stock

Benitec Biopharma ROA 2024

Benitec Biopharma ROA

-4.39

Ticker

BNTC

ISIN

US08205P1003

WKN

722783

In 2024, Benitec Biopharma's return on assets (ROA) was -4.39, a 43.78% increase from the -3.05 ROA in the previous year.

Benitec Biopharma Aktienanalyse

What does Benitec Biopharma do?

Benitec Biopharma Inc is a biopharmaceutical company based in the United States that focuses on developing groundbreaking therapies for the treatment of serious diseases. The company was founded in 1995 and is headquartered in Hayward, California. Benitec Biopharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Benitec Biopharma's Return on Assets (ROA)

Benitec Biopharma's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Benitec Biopharma's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Benitec Biopharma's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Benitec Biopharma’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Benitec Biopharma stock

What is the Return on Assets (ROA) of Benitec Biopharma this year?

The Return on Assets (ROA) of Benitec Biopharma is -4.39 undefined this year.

What was the ROA of Benitec Biopharma compared to the previous year?

The ROA of Benitec Biopharma has increased by 43.78% compared to the previous year.

What consequences do high ROA have for investors of Benitec Biopharma?

A high ROA is advantageous for investors of Benitec Biopharma, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Benitec Biopharma?

A low ROA can be unfavorable for investors of Benitec Biopharma as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Benitec Biopharma affect the company?

An increase in ROA of Benitec Biopharma can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Benitec Biopharma impact the company?

A reduction in the ROA of Benitec Biopharma can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Benitec Biopharma?

Some factors that can influence the ROA of Benitec Biopharma include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Benitec Biopharma important for investors?

The ROA of Benitec Biopharma is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Benitec Biopharma take to improve ROA?

To improve ROA, Benitec Biopharma can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Benitec Biopharma pay?

Over the past 12 months, Benitec Biopharma paid a dividend of 0.04 USD . This corresponds to a dividend yield of about 0.49 %. For the coming 12 months, Benitec Biopharma is expected to pay a dividend of 0 USD.

What is the dividend yield of Benitec Biopharma?

The current dividend yield of Benitec Biopharma is 0.49 %.

When does Benitec Biopharma pay dividends?

Benitec Biopharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Benitec Biopharma?

Benitec Biopharma paid dividends every year for the past 0 years.

What is the dividend of Benitec Biopharma?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Benitec Biopharma located?

Benitec Biopharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Benitec Biopharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Benitec Biopharma from 6/8/2018 amounting to 0.003 USD, you needed to have the stock in your portfolio before the ex-date on 6/1/2018.

When did Benitec Biopharma pay the last dividend?

The last dividend was paid out on 6/8/2018.

What was the dividend of Benitec Biopharma in the year 2023?

In the year 2023, Benitec Biopharma distributed 0 USD as dividends.

In which currency does Benitec Biopharma pay out the dividend?

The dividends of Benitec Biopharma are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Benitec Biopharma

Our stock analysis for Benitec Biopharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Benitec Biopharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.